Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14).
Am J Hematol
; 96(8): 925-933, 2021 08 01.
Article
in En
| MEDLINE
| ID: mdl-33901326
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonamides
/
Bridged Bicyclo Compounds, Heterocyclic
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
Am J Hematol
Year:
2021
Document type:
Article
Affiliation country: